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1. Introduction 
The induction of lethal UTP deficiency by uridylate- 
trapping sugar analogs [ 1 ] depends on a relatively low 
rate of pyrimidine nucleotide biosynthesis [2]. 
Increased activities of enzymes involved in the de novo 
synthesis of pyrimidine nucleotides have been demon- 
strated in a spectrum of hepatomas [3,4]. The resis- 
tance of solid hepatomas [5] and of ascites hepatoma 
cells to the action of D-galactosamine (GalN) has been 
explained by the efficient compensation of uridylate 
trapping by de novo synthesis resulting in only a 
limited depression of UTP [6]. Noncompensated 
uridylate trapping can be induced by the synergistic 
action of GalN and an inhibitor of de novo pyrimidine 
synthesis. A potent inhibitor of aspartate carbamoyl- 
transferase (EC 2.1.3.2) has been introduced recently 
[7-lo]. N-(Phosphonacetyl)-Laspartate (PALA) has 
been synthesized by Collins and Stark [7] as a transi- 
tion state intermediate analog of the aspartate carba- 
moyltransferase reaction and inhibits the enzyme in a 
number of cells and tissues [8,9]. PALA is a competi- 
tive inhibitor with respect to carbamoylphosphate and 
has a Ki of about 10W9 mol/l for the enzyme from 
mammalian cells [9,10]. 
This paper demonstrates the depression of de novo 
uridylate synthesis and UTP contents by PALA in 
ascites hepatoma cells. The depression of UTP by either 
PALA or GalN is insufficient, however, for a complete 
and irreversible inhibition of hepatoma cell growth in 
suspension culture. Only the combination of GalN- 
induced uridylate trapping with the blockage of 
de novo pyrimidine synthesis results in severe UTP 
deficiency and cellular death. 
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2. Materials and methods 
2.1. Chemicals and enzymes 
D-Galactosamine . HCl was purchased from C. Roth, 
Karlsruhe, FRG. N-(Phosphonacetyl)-Laspartate 
(PALA) was obtained from Dr G. Stark, Department 
of Biochemistry, Stanford University School of 
Medicine, Calif. 94305, USA. Swim’s medium S-77 
and Swim’s 67-G medium were from Grand Island 
Biological Company, Grand Island, NY, USA; the 
uridine, cofactors, and enzymes used in this investiga- 
tion were from Boehringer Mannheim, FRG. 
2.2. Incubation and suspension culture of ascites 
hepatoma cells 
The transplantable ascites hepatoma AS-30D [ 1 l] 
was carried in female Sprague-Dawley rats, the tumor 
cells were collected and incubated as described previ- 
ously [ 121. Transplant generations 426-436 were 
used in the present study. AS-30D cells were grown at 
37°C under COJair (S/100) in primary suspension 
cultures on a gyratory shaker at cell concentrations 
between 2 and 10 X lo’/1 in Swim’s 67 G medium 
supplemented with glutamine (2 mmol/l), sodium 
phosphate (2 mmol/l) and ascitic fluid (9/100 by vol.) 
sterilized by filtration of AS30D ascites hepatoma 
fluid. Proliferation and growth were monitored by cell 
counts in a blood counting chamber and by measure- 
ment of the absorbance of the suspensions at 623 nm; 
the latter correlated linearly with the cell wet weight 
in the concentration range studied. 
2.3. Nucleotide analyses 
Our procedure for freezing and deproteinization of 
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the cells has been described [ 121. Total acid-soluble 
uracil S’nucleotides (ZUMP) were measured as UMP 
after snake venom phosphodiesterase hydrolysis [ 131. 
Total adenine and guanine 5’-nucleotides @AMP and 
CGMP) [ 131, UDP-glucose, UTP, UDP [ 141 and ATP 
[ 1.51 were assayed enzymatically. 
3. Results 
3.1. Inhibition of de novo uridylate synthesis by PALA 
Incubation of AS30D cells in the presence of GalN 
(0.5 mmol/l) elicited an increase of total uracil nucleo- 
tides (ZUMP) at a rate of about 0.8 mmol X h-i X 
(kg cells)-’ between 1 and 4 h (fig.1). Inhibition of 
aspartate carbamoyltransferase by PALA resulted in a 
dose-dependent suppression of this GalN-induced stimu- 
lation of de novo pyrimidine synthesis. PALA alone 
caused only a minor decrease of EUMP when compared 
to control cells (fig.1). A complete suppression of the 
GalN-induced increase of EUMP by PALA (0.8 mmol/ 
1) and a more pronounced decrease of CUMP induced 
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Fig.1. Changes in total acid-soluble uracil nucleotides (ZUMP) 
induced by GalN and PALA. AS-30D cells were incubated in 
standard medium [ 121 at 37°C at cell concentrations of 
1.8-2.4 X 109/1. The pH was kept between 7.45 and 7.25. 
Nucleotide contents are based on cell wet weights determined 
3 times during the incubation [ 121. Duplicate analyses from 
separate experiments under the same condition differed by 
less than 15%. The concentration of GalN was 0.5 mmol/l 
throughout; the concentration of PALA was 0.8 mmol/l 
(open triangles) or as otherwise indicated. 
by PALA alone were seen when the concentration of 
Pi in the incubation medium was lowered from 26 
[ 121 to 2 mmol/l. 
3.2. Induction of selective UTP deficiency by noncom- 
pensated uridylate trapping 
The efficient compensation of the GalN-induced 
trapping of uridylate was indicated by the rate of 
increase of ZUMP (fig.1) which was more than 2 times 
higher than in liver [ I] and by the limited depression 
of UTP when the cells were incubated in the presence 
of GalN (fig.2). Inhibition of aspartate carbamoyltrans- 
ferase led to a 60% reduction of the UTP content after 
4 h (fig.2). This depressed UTP level still corresponds 
to the control range in rat liver [ 161. The combination 
of uridylate trapping with the inhibitory effect of 
PALA resulted in a synergistic depression of UTP in 
these hepatoma cells to contents below 0.05 mmol/kg 
(fig.2). 
The use of a low GalN concentration (0.5 mmol/l) 
enabled the induction of a selective UTP deficiency 
rather than a genera1 depression of nucleotide contents 
seen with GalN concentrations above 1 mmol/l [ 121. 
Neither PALA nor GalN nor combinations of both had 
any significant effect on the contents of total adenine 
@AMP) and guanine nucleotides (ZGMP) or ATP 
during the 4 h of incubation. These purine nucleotides 
remained within the control ranges determined earlier 
in AS-30D cells [ 121. It was remarkable that the 
TIME(h) 
Fig.2. Depression of UTP contents induced by GalN and PALA. 
The experimental conditions were the same as described under 
fig.1. The concentrations of GalN and PALA were 0.5 and 
0.8 mmol/l, respectively. 
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induction of UTP deficiency in these UDP-glucose- 
deficient cells [ 121 was not associated with a further 
depression of UDP-glucose which remained in a range 
of 0.03-0.07 mmol/kg. 
Uridine (0.5 mmol/l) prevented or reversed the 
depression of UTP induced by GalN and PALA. UTP 
contents remained between 0.76 and 0.56 mmol/kg 
when AS-30D cells were incubated as described under 
fig.2 in the presence of uridine + GalN + PALA. 
3.3. Synergistic inhibition of cell growth in suspension 
culture induced by PALA and GalN 
A depression of the growth rate was observed when 
AS-30D cells were cultured in the presence of PALA 
or GalN (0.6 mmol/l each). A complete cessation of 
growth and proliferation of the cells was induced by 
the combined action of both drugs (fig.3). Examination 
of the cells after 23 h in culture by phase contrast 
microscopy and staining with trypan blue (final con- 
centration 2 g/l) indicated more than 96% of intact cells 
in the controls and in cultures treated with either GalN 
or PALA. One third of the cells exposed to GalN + 
PALA took up trypan blue, cytoplasmic protrusions 
and/or cytonecrosis were seen in about 45%. 
The addition of uridine (0.5 mmol/l) to the cultures 
(fig.3) after 25 h completely failed to restore growth 
or proliferation of cells treated with GalN + PALA 
Fig.3. Depression of cell growth in suspension culture induced 
by PALA and GalN. Cultures were initiated at a concentration 
of 4 X 10’ cells/l and growth was monitored by measurement 
of the absorbance of the suspension at 623 nm. The concen- 
trations of PALA and GalN were 0.6 mmol/l each. 
whereas cell growth continued in cultures grown in the 
presence of GalN or PALA. This indicated irreparable 
cell damage and irreversible loss of cell growth induced 
by severe UTP deficiency (< 0.05 mmol/kg, see fig.2) 
by 25 h. 
4. Discussion 
The limited depression of UTP contents in AS-30D 
cells induced by GalN (fig.2) is sufficient for triggering 
an increase in the rate of de novo pyrimidine synthesis. 
In previous work this increase was suppressed by the 
use of 6-azauridine [ 1,6,17] which leads to an inhibi- 
tion of orotidine 5’-phosphate decarboxylase [ 181. 
Inhibition of aspartate carbamoyltransferase by PALA 
[7,10] also causes a suppression of the GalN-induced 
increase in ZUMP (fig.1). The available evidence indi- 
cates that de novo pyrimidine nucleotide synthesis in 
mammalian cells is regulated by feedback inhibition 
of glutamine-dependent carbamoyl-phosphate synthe- 
tase (EC 2.7.2.9) by UTP [ 19-2 1 ] . Lowering of the 
intracellular UTP concentration by GalN should mar- 
kedly increase the accumulation of carbamoyl phos- 
phate induced by an inhibition of aspartate carbamoyl- 
transferase. This would provide further convincing 
evidence for the operation of the feedback inhibition 
of glutamine-dependent carbamoyl-phosphate synthe- 
tase by UTP in intact cells. 
The inducation of lethal UTP deficiency by the 
synergistic action of PALA and uridylate trapping 
may serve as a new approach to the chemotherapy of 
hepatomas. PALA, in contrast to 6-azauridine, allows 
a selective protection of the liver by means of orotate. 
Orotate pretreatment has been shown to prevent the 
liver injury caused by GalN-induced UTP deficiency 
[22]. As compared to liver, orotate uptake by a wide 
range of experimental hepatomas including the most 
slowly growing tumors, has been shown to be very low 
[23,24]. Orotate (0.5 mmol/l) also has no detectable 
effect on the UTP contents of AS-30D cells incubated 
in the presence or absence of GalN [ 171. The concen- 
trations of PALA required for inhibition of de novo 
pyrimidine synthesis (fig.1) and depression of cell 
growth (fig.3) in AS-30D cells are higher than the effec- 
tive concentrations in transformed hamster cells 
(Cl 3/SV) and mouse cells (SV 3T3) [IO] . The toxicity 
of PALA in the latter cell lines is completely prevented 
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by addition of uridine to the culture medium [IO] . 
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